Trials / Recruiting
RecruitingNCT06128720
Hyperbaric Oxygen Therapy for Optic Neuropathies
A Randomized, Sham Controlled, Masked Phase II Study to Evaluate the Neuroprotective Effect of Hyperbaric Oxygen Therapy on Optic Neuropathy
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hyperbaric Oxygen | Participant will undergo 60 minutes of Hyperbaric oxygen at 1.5ATA while breathing 100% oxygen |
| DEVICE | Sham Hyperbaric Oxygen | Participant will undergo 60 minutes of Sham Hyperbaric Oxygen at atmospheric pressure while breathing room air. |
Timeline
- Start date
- 2022-11-01
- Primary completion
- 2027-06-01
- Completion
- 2027-12-01
- First posted
- 2023-11-13
- Last updated
- 2025-05-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06128720. Inclusion in this directory is not an endorsement.